Myeloma Minute: A new way to manage myeloma?

 

   
Myeloma Minute Banner.png
November 17, 2016
Mail Logo.png Facebook Logo.png Twitter Logo.png
   Youtube Logo.png
Clinical Trials Logo.jpg Donate Logo.jpg
 

 Ask Dr. Durie Logo.png
This week's question:

Is it safe to have surgery if my myeloma is in remission?

Featured Clinical Trials Logo.png
Multiple Myeloma Bone Study

New ARROW Clinical Trials: Learn How To Participate

New Selinexor STORM Clinical Trials: Learn How To Participate

New Ixazomib Clinical Trials: Learn How To Participate

Join the conversation about myeloma on the Smart Patients Message Board

Upcoming Events

Amazon Holiday Shopping Image.jpg

Start Your Holiday Shopping!
Donating to the IMF is easy
at amazon.myeloma.org

 

ASH Annual Meeting.jpg

December 3-6, 2016
58th ASH Annual Meeting

San Diego, California

LWM_PreASH2016_Cover.jpg

Replay Coming Soon!
Pre-ASH- What Patients & Caregivers Need to Know
 

Boca P&F.jpg

March 17-18, 2017
Patient & Family Seminar
Boca Raton, FL

 

Short Hills, NJ P&F.jpg

April 7-8, 2017
Patient & Family Seminar
Short Hills, New Jersey

 

 

 

 

 

 

 

 

 

 

Early Screening Project Points to a New Way to Manage Disease

iStopMM_TeamPhoto.jpg

The IMF Black Swan Research Initiative®-funded iStopMM project, an ambitious screening, treatment, and prevention program for MGUS, SMM, and MM, launched this week in Reykjavik, Iceland with great fanfare. Iceland President Guðni Jóhannesson joined iStopMM study leader Dr. Sigurdur Kristinsson at a press conference Tuesday, and pledged his participation in the study. Jóhannesson is among the approximately 140,000 Icelanders over the age 40 eligible for the screening effort. During a television news segment about iStopMM, which aired Monday night, IMF Chairman Dr. Brian Durie explained the study’s implications for myeloma, “Early diagnosis provides the best opportunity for curative therapy.” To read Dr. Durie’s blog, click HERE.

 

Amgen Announces Collaboration with Janssen to Co-Fund Studies with KYPROLIS® (Carfilzomib) and DARZALEX® (Daratumumab) in Patients with Multiple Myeloma

 
Medicine Pics.jpg

On Monday, November 10, 2016, Amgen announced a collaboration with Janssen Biotech, Inc. to evaluate the combination of Amgen's KYPROLIS® (carfilzomib) and Janssen's DARZALEX® (daratumumab) in multiple clinical studies in patients with multiple myeloma. Under the terms of the agreement, the companies may elect to supply drug only or supply drug and share development costs on a case-by-case basis for each study. Learn more HERE.

 

Seventy-five-year-old Runner and Myeloma Patient Laces Up for His 100th Marathon

 
100th Marathon.jpg

On November 20, 2016, multiple myeloma patient Don Wright will be lacing up his running shoes for his 100th marathon in Philadelphia to raise cancer awareness. In 2012, Don Wright doubted that he would be able to reach his first goal: running one marathon in each of the 50 states. After conquering that milestone, Don set another, which he hopes to accomplish with this 100th race. Diagnosed with multiple myeloma at the age of 62, Don was told that his expectation for survival was fewer than five years. Now,13 years later, Don credits a new medication—a pill—that he began taking while it was still in clinical trial.  It helped keep his cancer in check while he remained free to race around the US. When the cancer showed signs of a flare up, his doctors added one of the new immune-boosting treatments to his regimen. Don’s running also helps raise awareness of the progress the IMF has supported and the clinical trials run by leading myeloma experts in the International Myeloma Working group (IMWG). We wish Don the all the best for when he hits the starting blocks for the Philadelphia Marathon.   

 

 

With CyberMonday Only 10 Days Away, Learn How You Can Give to the IMF While You Shop Online!

 
Cyber Monday Gift Boxes.jpg

The IMF has a new Amazon link. Whether you shop on Amazon for the holidays or for your daily needs, please bookmark the brand new amazon.myeloma.org ., and delete our old Amazon link. At no added cost to you, Amazon will donate a percentage of your total purchase to the IMF. The percentage that Amazon donates to the IMF will continue to increase—even more than 7% at times—depending on how many orders are placed through the IMF portal. Donating to the IMF is as easy as a point-and-click at amazon.myeloma.org.

 

 
   
 

 

 

 

   

 

   

  

 

                                                                We Would Like to Thank Our Sponsors:
 
Takeda Oncology, Celgene, Amgen, and Bristol-Myers Squibb
 

 

.

 

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.